טוען...
Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma
BACKGROUND: MicroRNA-106b (miR-106b) is a member of the miR-106b ~ 25 cluster. It has been reported that miR-106b acts as an oncogene and is upregulated in many human cancers. However, the prognostic value of miR-106b in hepatocellular carcinoma (HCC) remains unclear. The aim of this study was to in...
שמור ב:
| הוצא לאור ב: | Diagn Pathol |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261545/ https://ncbi.nlm.nih.gov/pubmed/25466449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-014-0226-4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|